383 related articles for article (PubMed ID: 15493726)
1. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.
Kale A; Bayhan G; Yalinkaya A; Yayla M
J Perinat Med; 2004; 32(5):456-8. PubMed ID: 15493726
[TBL] [Abstract][Full Text] [Related]
2. Glanzmann's thrombasthenia in pregnancy: a case and review of the literature.
Sherer DM; Lerner R
Am J Perinatol; 1999; 16(6):297-301. PubMed ID: 10586983
[TBL] [Abstract][Full Text] [Related]
3. The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy.
Erduran E; Aksoy A; Zaman D
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):215-7. PubMed ID: 19657319
[TBL] [Abstract][Full Text] [Related]
4. [Pregnancy and labor in a primigravida with Glanzmann's thrombasthenia].
Pomili G; Servidio F; Vezza R; Ricotta S; Gresele P; Gilardi G
Minerva Ginecol; 1994 Mar; 46(3):129-32. PubMed ID: 8015698
[TBL] [Abstract][Full Text] [Related]
5. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
Javed A; Ayyub M; Abrar S; Mansoor M; Khan B; Hussain T
J Ayub Med Coll Abbottabad; 2009; 21(2):171-3. PubMed ID: 20524499
[TBL] [Abstract][Full Text] [Related]
6. New Insights Into the Treatment of Glanzmann Thrombasthenia.
Poon MC; Di Minno G; d'Oiron R; Zotz R
Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
[TBL] [Abstract][Full Text] [Related]
7. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.
Franchini M; Lippi G
Expert Rev Hematol; 2014 Dec; 7(6):733-40. PubMed ID: 25387838
[TBL] [Abstract][Full Text] [Related]
8. [Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia].
Sugihara S; Katsutani S; Hyodo H; Hyodo M; Kudo Y; Fujii T; Kimura A
Rinsho Ketsueki; 2008 Jan; 49(1):46-50. PubMed ID: 18277596
[TBL] [Abstract][Full Text] [Related]
9. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
Poon MC; Zotz R; Di Minno G; Abrams ZS; Knudsen JB; Laurian Y
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy in a patient of Glanzmann's thrombasthenia with antiplatelet antibodies.
Kashyap R; Kriplani A; Saxena R; Takkar D; Choudhry VP
J Obstet Gynaecol Res; 1997 Jun; 23(3):247-50. PubMed ID: 9255036
[TBL] [Abstract][Full Text] [Related]
11. Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia.
van Buuren HR; Wielenga JJ
Dig Dis Sci; 2002 Sep; 47(9):2134-6. PubMed ID: 12353868
[TBL] [Abstract][Full Text] [Related]
12. Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues.
Di Minno G; Coppola A; Di Minno MN; Poon MC
Thromb Haemost; 2009 Dec; 102(6):1157-64. PubMed ID: 19967146
[TBL] [Abstract][Full Text] [Related]
13. Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia.
Kadowaki S; Makino S; Mohri Y; Awaguni H; Shinozuka J; Imashuku S
Blood Coagul Fibrinolysis; 2021 Mar; 32(2):155-158. PubMed ID: 33196513
[TBL] [Abstract][Full Text] [Related]
14. Glanzmann's thrombasthenia proposed optimal management during surgery and delivery.
Bell JA; Savidge GF
Clin Appl Thromb Hemost; 2003 Apr; 9(2):167-70. PubMed ID: 12812388
[TBL] [Abstract][Full Text] [Related]
15. Perioperative management of Glanzmann's syndrome: how we did it!
Depner C; Schmid R; Kirchhoff P; Oertli D
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):283-4. PubMed ID: 20182353
[TBL] [Abstract][Full Text] [Related]
16. Glanzmann's thrombasthenia and pregnancy.
Walters JP; Hall JS
West Indian Med J; 1990 Dec; 39(4):256-8. PubMed ID: 2082573
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey.
Poon MC; D'Oiron R; Von Depka M; Khair K; Négrier C; Karafoulidou A; Huth-Kuehne A; Morfini M;
J Thromb Haemost; 2004 Jul; 2(7):1096-103. PubMed ID: 15219192
[TBL] [Abstract][Full Text] [Related]
18. Dental considerations for a Glanzmann's thrombasthenia patient: case report.
Bisch FC; Bowen KJ; Hanson BS; Kudryk VL; Billman MA
J Periodontol; 1996 May; 67(5):536-40. PubMed ID: 8724714
[TBL] [Abstract][Full Text] [Related]
19. Severe juvenile vaginal bleeding due to Glanzmann's thrombasthenia: case report and review of the literature.
Markovitch O; Ellis M; Holzinger M; Goldberger S; Beyth Y
Am J Hematol; 1998 Mar; 57(3):225-7. PubMed ID: 9495374
[TBL] [Abstract][Full Text] [Related]
20. Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies.
Martin I; Kriaa F; Proulle V; Guillet B; Kaplan C; D'Oiron R; Debré M; Fressinaud E; Laurian Y; Tchernia G; Charpentier B; Lambert T; Dreyfus M
Br J Haematol; 2002 Dec; 119(4):991-7. PubMed ID: 12472579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
